Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Fluid-enhanced surface diffusion controls intraparticle phase transformations.

Li Y, Chen H, Lim K, Deng HD, Lim J, Fraggedakis D, Attia PM, Lee SC, Jin N, Moškon J, Guan Z, Gent WE, Hong J, Yu YS, Gaberšček M, Islam MS, Bazant MZ, Chueh WC.

Nat Mater. 2018 Oct;17(10):915-922. doi: 10.1038/s41563-018-0168-4. Epub 2018 Sep 17.


Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer's Disease Prevention.

Schelke MW, Attia P, Palenchar DJ, Kaplan B, Mureb M, Ganzer CA, Scheyer O, Rahman A, Kachko R, Krikorian R, Mosconi L, Isaacson RS.

Front Aging Neurosci. 2018 Apr 10;10:96. doi: 10.3389/fnagi.2018.00096. eCollection 2018. Review.


Mega-sized concerns from the nano-sized world: the intersection of nano- and environmental ethics.

Attia P.

Sci Eng Ethics. 2013 Sep;19(3):1007-16. doi: 10.1007/s11948-012-9422-3. Epub 2012 Dec 6.


Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration.

Powell DJ Jr, Attia P, Ghetie V, Schindler J, Vitetta ES, Rosenberg SA.

J Immunother. 2008 Feb-Mar;31(2):189-98. doi: 10.1097/CJI.0b013e31815dc0e8.


Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma.

Maker AV, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Hughes M, Yellin MJ, Haworth LR, Levy C, Allen T, Mavroukakis SA, Attia P, Rosenberg SA.

J Immunother. 2006 Jul-Aug;29(4):455-63.


Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2.

Attia P, Powell DJ Jr, Maker AV, Kreitman RJ, Pastan I, Rosenberg SA.

J Immunother. 2006 Mar-Apr;29(2):208-14.


Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.

Maker AV, Phan GQ, Attia P, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Haworth LR, Levy C, Kleiner D, Mavroukakis SA, Yellin M, Rosenberg SA.

Ann Surg Oncol. 2005 Dec;12(12):1005-16. Epub 2005 Oct 21.


Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Haworth LR, Levy C, Mavroukakis SA, Nichol G, Yellin MJ, Rosenberg SA.

J Clin Oncol. 2005 Sep 1;23(25):6043-53. Epub 2005 Aug 8.


Supplemental Content

Loading ...
Support Center